Prostate Cancer Therapy Resistance: the Genetic, Epigenetic and Metabolic Connections-2025 Prostate Cancer International Symposium (PCIS25)
2025 Prostate Cancer International Symposium （PCIS25）-The Genetic, Epigenetic, and Metabolic Connections, focuses on the latest insights into molecular mechanisms, biomarkers, and therapeutic strategies.
About the Symposium
The 2025 Prostate Cancer International Symposium （PCIS25） brings together world-renowned experts, researchers, and clinicians to discuss cutting-edge advancements in prostate cancer therapy resistance. This year’s theme, Prostate Cancer Therapy Resistance: The Genetic, Epigenetic, and Metabolic Connections, focuses on the latest insights into molecular mechanisms, biomarkers, and therapeutic strategies.
Distinguished Speakers from leading institutions such as Johns Hopkins University, Dana-Farber Cancer Institute, University of California, Duke University, UBC, NHRI, Academia Sinica, and Taipei Medical University (TMU), and its affiliated hospital.
Networking Opportunities with global experts in prostate cancer research.
Join us for an insightful exchange of groundbreaking research, emerging technologies, and collaborative opportunities in the fight against prostate cancer therapy.
Registration Information
Registration Deadline: April 7, 2025
Register Now: Click here to register
Quick Registration: Scan the QR code on the poster below
The event has been approved for 11 hours of continuing education credits within the university.
Don't miss this exceptional opportunity to join a global discussion on prostate cancer research and treatment!